المؤلفون: Chen, RY, Via, LE, Dodd, LE, Walzl, G, Malherbe, ST, Loxton, AG, Dawson, R, Wilkinson, RJ, Thienemann, F, Tameris, M, Hatherill, M, Diacon, AH, Liu, X, Xing, J, Jin, X, Ma, Z, Pan, S, Zhang, G, Gao, Q, Jiang, Q, Zhu, H, Liang, L, Duan, H, Song, T, Alland, D, Tartakovsky, M, Rosenthal, A, Whalen, C, Duvenhage, M, Cai, Y, Goldfeder, LC, Arora, K, Smith, B, Winter, J, Barry Iii, CE, Predict TB Study Group

المساهمون: European and Developing Countries Clinical Trials Partnership

مصطلحات موضوعية: Model organisms, Human Biology & Physiology, drug sensitive, treatment shortening, PET/CT, FOS: Clinical medicine, Immunology, biomarkers, GeneXpert, Infectious Disease, MERM, pulmonary tuberculosis, cycle threshold

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf92b84578644929cf424244724f99ac

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Chen RY; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Yu X; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA., Smith B; DST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Liu X; Henan Provincial Chest Hospital, Zhengzhou, Henan, China., Gao J; Sino-US Tuberculosis Collaborative Research Program, Zhengzhou, Henan, China., Diacon AH; Department of Medicine, Stellenbosch University, Cape Town, South Africa.; TASK Applied Science, Cape Town, South Africa., Dawson R; Division of Pulmonology, Department of Medicine, University of Cape Town Lung Institute, University of Cape Town, Cape Town, South Africa., Tameris M; South African Tuberculosis Vaccine Initiative, University of Cape Town, Cape Town, South Africa., Zhu H; Sino-US Tuberculosis Collaborative Research Program, Zhengzhou, Henan, China., Qu Y; Kaifeng City Institute of Tuberculosis Prevention and Control, Kaifeng, Henan, China., Zhang R; Xinxiang City Institute of Tuberculosis Prevention and Control, Xinxiang, Henan, China., Pan S; Zhongmu County Health and Epidemic Prevention Station, Zhongmu, Henan, China., Jin X; Xinmi City Institute of Tuberculosis Prevention and Control, Xinmi, Henan, China., Goldfeder LC; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA., Cai Y; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA., Arora K; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA., Wang J; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Vincent J; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA., Malherbe ST; DST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Thienemann F; Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Department of Internal Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Wilkinson RJ; Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town, South Africa.; Francis Crick Institute, London, UK.; Department of Infectious Diseases, Imperial College London, London, UK., Walzl G; DST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Barry CE 3rd; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

المصدر: The Lancet. Microbe [Lancet Microbe] 2021 Oct; Vol. 2 (10), pp. e518-e526.

نوع المنشور: Journal Article; Observational Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print Cited Medium: Internet ISSN: 2666-5247 (Electronic) Linking ISSN: 26665247 NLM ISO Abbreviation: Lancet Microbe

مواضيع طبية MeSH: HIV Infections*/drug therapy , Tuberculosis, Lymph Node*/drug therapy , Tuberculosis, Pulmonary*/diagnostic imaging, Anti-Bacterial Agents/therapeutic use ; Fluorodeoxyglucose F18/therapeutic use ; Humans ; Inflammation/drug therapy ; Positron Emission Tomography Computed Tomography ; Prospective Studies ; Rifampin/therapeutic use ; Sensitivity and Specificity ; United States

المؤلفون: Xie YL; Division of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, USA., de Jager VR; TASK Applied Science, Cape Town 7500, South Africa., Chen RY; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892, USA.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa., Dodd LE; Biostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892, USA., Paripati P; Imaging Group, NET ESolutions Inc., McLean, VA 22102, USA., Via LE; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892, USA.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa., Follmann D; Biostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892, USA., Wang J; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., Lumbard K; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., Lahouar S; Imaging Group, NET ESolutions Inc., McLean, VA 22102, USA., Malherbe ST; Department of Science and Technology-National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7600, South Africa., Andrews J; Microbial Pathogenesis, Yale University, New Haven, CT 06520, USA., Yu X; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892, USA., Goldfeder LC; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892, USA., Cai Y; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892, USA., Arora K; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892, USA., Loxton AG; Department of Science and Technology-National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7600, South Africa., Vanker N; TASK Applied Science, Cape Town 7500, South Africa., Duvenhage M; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., Winter J; Catalysis Foundation for Health, San Ramon, CA 94583, USA., Song T; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa., Walzl G; Department of Science and Technology-National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7600, South Africa., Diacon AH; TASK Applied Science, Cape Town 7500, South Africa.; Department of Medicine, Stellenbosch University, Cape Town 7505, South Africa., Barry CE 3rd; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892, USA. cbarry@niaid.nih.gov.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.

المصدر: Science translational medicine [Sci Transl Med] 2021 Feb 03; Vol. 13 (579).

نوع المنشور: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

مواضيع طبية MeSH: Tuberculosis*/diagnostic imaging , Tuberculosis*/drug therapy , Tuberculosis, Pulmonary*/diagnostic imaging , Tuberculosis, Pulmonary*/drug therapy, Antitubercular Agents/therapeutic use ; Drug Combinations ; Drug Therapy, Combination ; Fluorodeoxyglucose F18 ; Humans ; Positron Emission Tomography Computed Tomography

المؤلفون: Chen RY; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Via LE; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.; Wellcome Centre for Infectious Diseases Research in Africa,Institute of Infectious Disease and Molecular Medicine, University of Cape Town (UCT), Cape Town, South Africa., Dodd LE; Biostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Walzl G; South Africa Department of Science and Technology - National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Malherbe ST; South Africa Department of Science and Technology - National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Loxton AG; South Africa Department of Science and Technology - National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Dawson R; Division of Pulmonology, Department of Medicine, University Of Cape Town Lung Institute, University of Cape Town (UCT), Cape Town, South Africa., Wilkinson RJ; Wellcome Centre for Infectious Diseases Research in Africa,Institute of Infectious Disease and Molecular Medicine, University of Cape Town (UCT), Cape Town, South Africa.; Francis Crick Institute, London, NW1 2AT, UK.; Department of Medicine, Imperial College London, London, W2 1PG, UK., Thienemann F; Wellcome Centre for Infectious Diseases Research in Africa,Institute of Infectious Disease and Molecular Medicine, University of Cape Town (UCT), Cape Town, South Africa.; Department of Internal Medicine, University Hospital Zurich, Zurich, Switzerland., Tameris M; South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT), Cape Town, South Africa., Hatherill M; South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT), Cape Town, South Africa., Diacon AH; TASK Applied Science and Stellenbosch University, Cape Town, South Africa., Liu X; Henan Provincial Chest Hospital, Zhengzhou, Henan, China., Xing J; Henan Provincial Institute of Tuberculosis and Prevention, Henan Center for Disease Control, Zhengzhou, Henan, China., Jin X; Xinmi City Institute of Tuberculosis Prevention and Control, Xinmi, Henan, China., Ma Z; Kaifeng City Institute of Tuberculosis Prevention and Control, Kaifeng, Henan, China., Pan S; Zhongmu County Health and Epidemic Prevention Station, Zhongmu, Henan, China., Zhang G; Henan Provincial Institute of Tuberculosis and Prevention, Henan Center for Disease Control, Zhengzhou, Henan, China., Gao Q; Fudan University, Shanghai, China., Jiang Q; Fudan University, Shanghai, China., Zhu H; Sino-US Tuberculosis Collaborative Research Program, Zhengzhou, Henan, China., Liang L; TASK Applied Science and Stellenbosch University, Cape Town, South Africa., Duan H; Beijing Chest Hospital, Beijing, China., Song T; Institute of Infectious Disease and Molecular Medicine, University of Cape Town (UCT), Cape Town, South Africa., Alland D; Division of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA., Tartakovsky M; Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Rosenthal A; Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Whalen C; Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Duvenhage M; Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Cai Y; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Goldfeder LC; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Arora K; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Smith B; South Africa Department of Science and Technology - National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Winter J; Catalysis Foundation for Health, Emeryville, CA, USA., Barry Iii CE; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.; Wellcome Centre for Infectious Diseases Research in Africa,Institute of Infectious Disease and Molecular Medicine, University of Cape Town (UCT), Cape Town, South Africa.

مؤلفون مشاركون: Predict TB Study Group

المصدر: Gates open research [Gates Open Res] 2017 Nov 06; Vol. 1, pp. 9. Date of Electronic Publication: 2017 Nov 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Bill and Melinda Gates Foundation Country of Publication: United States NLM ID: 101717821 Publication Model: Electronic Cited Medium: Internet ISSN: 2572-4754 (Electronic) Linking ISSN: 25724754 NLM ISO Abbreviation: Gates Open Res Subsets: PubMed not MEDLINE

المؤلفون: Liang L; Henan Provincial Chest Hospital, Zhengzhou, Henan., Shi R; Henan Provincial Chest Hospital, Zhengzhou, Henan., Liu X; Henan Provincial Chest Hospital, Zhengzhou, Henan., Yuan X; Henan Provincial Chest Hospital, Zhengzhou, Henan., Zheng S; Henan Provincial Chest Hospital, Zhengzhou, Henan., Zhang G; Henan Public Health Clinical Center, Zhengzhou, Henan, China., Wang W; Henan Provincial Chest Hospital, Zhengzhou, Henan., Wang J; Clinical Monitoring Research Program, Clinical Research Directorate, Leidos Biomedical Research, Inc, Frederick, Maryland., England K; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases., Via LE; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases., Cai Y; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases., Goldfeder LC; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases., Dodd LE; Biostatistics Research Branch, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA., Barry CE; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases., Chen RY; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases.

المصدر: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [Int J Tuberc Lung Dis] 2017 Oct 01; Vol. 21 (10), pp. 1145-1149.

نوع المنشور: Journal Article; Observational Study; Research Support, N.I.H., Intramural; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: The Union Country of Publication: France NLM ID: 9706389 Publication Model: Print Cited Medium: Internet ISSN: 1815-7920 (Electronic) Linking ISSN: 10273719 NLM ISO Abbreviation: Int J Tuberc Lung Dis Subsets: MEDLINE

مواضيع طبية MeSH: Antitubercular Agents/*therapeutic use , Interferon-gamma Release Tests/*methods , Tuberculosis/*drug therapy , Tuberculosis, Pulmonary/*drug therapy, Adult ; Case-Control Studies ; Cohort Studies ; Female ; Follow-Up Studies ; Humans ; Interferon-gamma/blood ; Male ; Prospective Studies ; Time Factors ; Treatment Outcome ; Tuberculosis/diagnosis ; Tuberculosis, Pulmonary/diagnosis

المؤلفون: Song T; International Tuberculosis Research Center, Changwon, Republic of Korea., Lee M; International Tuberculosis Research Center, Changwon, Republic of Korea., Jeon HS; International Tuberculosis Research Center, Changwon, Republic of Korea., Park Y; International Tuberculosis Research Center, Changwon, Republic of Korea., Dodd LE; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Dartois V; Public Health Research Institute, New Jersey Medical School, Rutgers, Newark, NJ, USA., Follman D; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Wang J; Clinical Research Directorate, Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Cai Y; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Goldfeder LC; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Olivier KN; Cardiovascular and Pulmonary Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Xie Y; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Via LE; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA; Department of Clinical Laboratory Sciences, Faculty of Health Sciences, University of Cape Town, Rondebosch, Cape Town, 7701, Republic of South Africa., Cho SN; Department of Microbiology and Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea., Barry CE 3rd; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA; Department of Clinical Laboratory Sciences, Faculty of Health Sciences, University of Cape Town, Rondebosch, Cape Town, 7701, Republic of South Africa., Chen RY; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

المصدر: EBioMedicine [EBioMedicine] 2015 Oct 09; Vol. 2 (11), pp. 1627-33. Date of Electronic Publication: 2015 Oct 09 (Print Publication: 2015).

نوع المنشور: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: eCollection Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE

مواضيع طبية MeSH: Antitubercular Agents/*administration & dosage , Antitubercular Agents/*adverse effects , Extensively Drug-Resistant Tuberculosis/*drug therapy , Extensively Drug-Resistant Tuberculosis/*metabolism , Linezolid/*administration & dosage , Linezolid/*adverse effects , Mitochondria/*drug effects , Mitochondria/*metabolism, Adult ; Antitubercular Agents/pharmacokinetics ; Comorbidity ; Drug Monitoring ; Extensively Drug-Resistant Tuberculosis/diagnosis ; Extensively Drug-Resistant Tuberculosis/immunology ; Female ; Genes, Mitochondrial ; Genes, rRNA ; Humans ; Linezolid/pharmacokinetics ; Male ; Middle Aged ; Polymorphism, Single Nucleotide ; Risk Factors

المؤلفون: Chen RY; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Dodd LE; Biostatistics Research Branch, NIAID, NIH, Bethesda, MD 20892, USA., Lee M; International Tuberculosis Research Center, Changwon 631-710, South Korea., Paripati P; NET Esolutions Corporation (NETE), NETE-FGI Imaging Team, McLean, VA 22102, USA., Hammoud DA; Division of Diagnostic Radiology, Clinical Center, NIH, Bethesda, MD 20892, USA., Mountz JM; Department of Radiology, University of Pittsburgh, Pittsburgh, PA 15260, USA., Jeon D; National Masan Hospital, Changwon 631-710, South Korea., Zia N; Department of Radiology, University of Pittsburgh, Pittsburgh, PA 15260, USA., Zahiri H; Division of Diagnostic Radiology, Clinical Center, NIH, Bethesda, MD 20892, USA., Coleman MT; Department of Radiology, University of Pittsburgh, Pittsburgh, PA 15260, USA., Carroll MW; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Lee JD; Department of Nuclear Medicine, Yonsei University College of Medicine, Seoul 120-752, South Korea., Jeong YJ; Department of Diagnostic Radiology, Pusan National University School of Medicine, Busan 609-735, South Korea., Herscovitch P; PET Department, Clinical Center, NIH, Bethesda, MD 20892, USA., Lahouar S; NET Esolutions Corporation (NETE), NETE-FGI Imaging Team, McLean, VA 22102, USA., Tartakovsky M; Office of Cyber Infrastructure and Computational Biology, NIAID, NIH, Bethesda, MD 20892, USA., Rosenthal A; Office of Cyber Infrastructure and Computational Biology, NIAID, NIH, Bethesda, MD 20892, USA., Somaiyya S; NET Esolutions Corporation (NETE), NETE-FGI Imaging Team, McLean, VA 22102, USA., Lee S; International Tuberculosis Research Center, Changwon 631-710, South Korea., Goldfeder LC; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Cai Y; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Via LE; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Park SK; National Masan Hospital, Changwon 631-710, South Korea., Cho SN; International Tuberculosis Research Center, Changwon 631-710, South Korea. Department of Microbiology and Institute of Immunology and Immunological Disease, Yonsei University College of Medicine, Seoul 120-752, South Korea., Barry CE 3rd; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA. Institute of Infectious Disease and Molecular Medicine, and the Department of Clinical Laboratory Sciences, Faculty of Health Sciences, University of Cape Town, Rondebosch 7701, South Africa. cbarry@niaid.nih.gov.

المصدر: Science translational medicine [Sci Transl Med] 2014 Dec 03; Vol. 6 (265), pp. 265ra166.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

مواضيع طبية MeSH: Positron-Emission Tomography* , Tomography, X-Ray Computed*, Tuberculosis, Multidrug-Resistant/*diagnostic imaging , Tuberculosis, Multidrug-Resistant/*therapy, Adult ; Algorithms ; Double-Blind Method ; Female ; Fluorodeoxyglucose F18 ; Humans ; Lung/diagnostic imaging ; Male ; Metronidazole/therapeutic use ; Multimodal Imaging ; Observer Variation ; Prospective Studies ; ROC Curve ; Radiographic Image Interpretation, Computer-Assisted ; Sensitivity and Specificity ; Software ; Sputum/microbiology ; Treatment Outcome

المؤلفون: Choi H, Lee M, Chen RY, Kim Y, Yoon S, Joh JS, Park SK, Dodd LE, Lee J, Song T, Cai Y, Goldfeder LC, Via LE, Carroll MW, Barry CE 3rd, Cho SN; International Tuberculosis Research Center, Changwon, Republic of Korea. raycho@yonsei.kr.

المصدر: BMC infectious diseases [BMC Infect Dis] 2014 Jul 02; Vol. 14, pp. 360. Date of Electronic Publication: 2014 Jul 02.

نوع المنشور: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Tuberculosis, Pulmonary/*epidemiology, Adult ; Antitubercular Agents/therapeutic use ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Republic of Korea/epidemiology ; Risk Factors ; Treatment Failure ; Treatment Outcome ; Tuberculosis, Multidrug-Resistant/drug therapy ; Tuberculosis, Multidrug-Resistant/epidemiology ; Tuberculosis, Pulmonary/drug therapy

المؤلفون: Carroll MW; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Jeon D, Mountz JM, Lee JD, Jeong YJ, Zia N, Lee M, Lee J, Via LE, Lee S, Eum SY, Lee SJ, Goldfeder LC, Cai Y, Jin B, Kim Y, Oh T, Chen RY, Dodd LE, Gu W, Dartois V, Park SK, Kim CT, Barry CE 3rd, Cho SN

المصدر: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2013 Aug; Vol. 57 (8), pp. 3903-9. Date of Electronic Publication: 2013 Jun 03.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Antitubercular Agents/*administration & dosage , Antitubercular Agents/*therapeutic use , Metronidazole/*administration & dosage , Metronidazole/*therapeutic use , Tuberculosis, Multidrug-Resistant/*drug therapy, Adult ; Antitubercular Agents/adverse effects ; Antitubercular Agents/pharmacokinetics ; Area Under Curve ; Confidence Intervals ; Double-Blind Method ; Female ; Humans ; Lung/microbiology ; Lung/pathology ; Male ; Metronidazole/adverse effects ; Metronidazole/pharmacokinetics ; Mycobacterium tuberculosis/isolation & purification ; Peripheral Nervous System Diseases/chemically induced ; Severity of Illness Index ; Sputum/microbiology ; Treatment Outcome ; Young Adult